Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1802632-22-9
2. Ct-1812
3. Ct1812
4. 2-(tert-butoxy)-4-(3-methyl-3-(5-(methylsulfonyl)isoindolin-2-yl)butyl)phenol
5. 0661v34ntv
6. 2-tert-butoxy-4-(3-(5-methanesulfonyl-1-1,3-dihydro-isoindol-1-yl)-3-methyl-butyl)-phenol
7. Unii-0661v34ntv
8. Chembl4846092
9. Schembl16972400
10. Bdbm349547
11. Bcp30368
12. Ex-a2998
13. Zb1519
14. At24038
15. Hy-111669
16. Cs-0089606
17. Us10207991, Ex. Cpd. No. 62
18. A935876
19. Ct 1812; Ct1812;sigma-2 Receptor Antagonist 1
20. 2243184-39-4
21. 4-[3-methyl-3-(5-methylsulfonyl-1,3-dihydroisoindol-2-yl)butyl]-2-[(2-methylpropan-2-yl)oxy]phenol
Molecular Weight | 431.6 g/mol |
---|---|
Molecular Formula | C24H33NO4S |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 7 |
Exact Mass | 431.21302971 g/mol |
Monoisotopic Mass | 431.21302971 g/mol |
Topological Polar Surface Area | 75.2 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 678 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A CT1812 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CT1812, including repackagers and relabelers. The FDA regulates CT1812 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CT1812 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CT1812 supplier is an individual or a company that provides CT1812 active pharmaceutical ingredient (API) or CT1812 finished formulations upon request. The CT1812 suppliers may include CT1812 API manufacturers, exporters, distributors and traders.
CT1812 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CT1812 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CT1812 GMP manufacturer or CT1812 GMP API supplier for your needs.
A CT1812 CoA (Certificate of Analysis) is a formal document that attests to CT1812's compliance with CT1812 specifications and serves as a tool for batch-level quality control.
CT1812 CoA mostly includes findings from lab analyses of a specific batch. For each CT1812 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CT1812 may be tested according to a variety of international standards, such as European Pharmacopoeia (CT1812 EP), CT1812 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CT1812 USP).
LOOKING FOR A SUPPLIER?